PLX
Protalix Biotherapeutics Inc
Price:  
2.84 
USD
Volume:  
911,275.00
Israel | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PLX Probability of Bankruptcy

The Probability of Bankruptcy of Protalix Biotherapeutics Inc (PLX) is 5.45% . This number represents the probability that PLX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating PLX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

PLX - ESG ratings

ESG ratings are directly linked to the cost of capital and PLX's ability to raise funding, both of which can significantly affect the probability of Protalix Biotherapeutics Inc going bankrupt.

ESG Score 69.11
Environment Score 74.53
Social Score 73.40
Governance Score 59.40
Returns
Historical Returns (5 day) -4.05%
Historical Returns (MTD) -7.49%
Historical Returns (YTD) 51.06%
Historical Returns (13 week) 16.87%
Historical Returns (26 week) 162.96%
Historical Returns (52 week) 144.83%
Efficiency
Asset Turnover 0.68
Receiveable Turnover 13.05
Gross Margin 54.46%
Operating Margin 7.34%
Pretax Margin 7.78%
Net Margin 5.49%
Return on Asset (ROA) 3.71
Return on Equity (ROE) 8.75
Return on Investments (ROI) 6.71
Price Metrics
Market Cap (M) 221.61
Enterprise Value (M)
52 Week High 3.10
52 Week Low 0.82
Beta -0.03
Average Volume (10 day) 0.94
Average Volume (3 month) 0.69
Price / Earnings (P/E) 75.94
Price / Sales (P/S) 4.17
Earnings
EPS 0.01
Revenue CAGR (5 year) -0.48%
Risk
Current Ratio 2.34
Quick Ratio 1.52